Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services. The company serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians’ practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is based in Glen Allen, Virginia.
Strategic Expansion | Explore Owens & Minor's $1.36 billion acquisition of Rotech, aimed at strengthening its position in the high-growth Patient Direct business |
Financial Challenges | Delve into the company's mixed Q3 results, revised guidance, and the implications of its recent CFO transition on financial stability |
Market Dynamics | Learn how Owens & Minor navigates industry shifts, including the impact of GLP-1 drugs and potential benefits from Chinese tariffs |
Analyst Perspectives | Discover varied analyst views on OMI's future, with price targets ranging from $14 to $23, reflecting both optimism and caution |
Metrics to compare | OMI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOMIPeersSector | |
---|---|---|---|---|
P/E Ratio | −1.7x | −1.1x | −0.5x | |
PEG Ratio | 0.00 | −0.01 | 0.00 | |
Price/Book | 1.1x | 1.1x | 2.6x | |
Price / LTM Sales | 0.1x | 1.0x | 3.2x | |
Upside (Analyst Target) | 14.2% | 76.6% | 41.9% | |
Fair Value Upside | Unlock | 17.8% | 4.3% | Unlock |